This inventor holds 17 USPTO granted patents and 3 published patent applications. Top assignees: Artecel Sciences Inc., Artecel Science, Inc., Artecel, Inc. Active years: 2000-2023.
Location History:
- Bahama, NC (US) (2000 - 2014)
- Raleigh, NC (US) (2021 - 2023)
Company Filing History:
7 out of 9 
2 out of 2 
2 out of 4 
Years Active: 2000-2023
Title: The Innovative Contributions of William O. Wilkison
Introduction
William O. Wilkison is a notable inventor based in Bahama, North Carolina, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in medical treatments, particularly in the field of diabetes management and post-prandial hypoglycemia.
Latest Patents
Among his latest patents is a method for treating post-prandial hypoglycemia. This patent discloses methods, sodium-dependent glucose transporter (SGLT)1 compounds, and compositions aimed at treating hypoglycemia that occurs as a consequence of gastric surgery. Another significant patent is a combination immediate/delayed release delivery system for short half-life pharmaceuticals, including remogliflozin. This innovative system provides a dosage form with two distinct phases of release, promoting immediate release upon ingestion while delaying further release to ensure effective control of plasma glucose levels.
Career Highlights
Throughout his career, Wilkison has made significant contributions to the field of medical technology. He has worked with companies such as Artecel Sciences Inc. and Artecel Science, Inc., where he has applied his expertise to develop groundbreaking solutions in healthcare.
Collaborations
Wilkison has collaborated with notable professionals in his field, including Jeffrey Martin Gimble and Yuan-Di Chang Halvorsen. These collaborations have further enhanced his innovative capabilities and contributions to medical science.
Conclusion
William O. Wilkison's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to improving healthcare solutions, particularly for individuals managing diabetes and related conditions.